Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/43784
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVegliante, Maria Carmela-
dc.contributor.authorRoyo Moreno, Cristina-
dc.contributor.authorPalomero, Jara-
dc.contributor.authorSalaverria Frigola, Itziar-
dc.contributor.authorBalint, Balazs-
dc.contributor.authorMartín Guerrero, Idoia-
dc.contributor.authorAgirre, Xabier-
dc.contributor.authorLujambio, Amaia-
dc.contributor.authorRichter, Julia-
dc.contributor.authorXargay i Torrent, Sílvia-
dc.contributor.authorBeà Bobet, Sílvia M.-
dc.contributor.authorHernández, Luís-
dc.contributor.authorEnjuanes, Anna-
dc.contributor.authorCalasanz, María José-
dc.contributor.authorRosenwald, Andreas-
dc.contributor.authorCampo Güerri, Elias-
dc.contributor.authorRomán-Gómez, José-
dc.contributor.authorProsper, Felipe-
dc.contributor.authorEsteller, Manel-
dc.contributor.authorJares Gerboles, Pedro-
dc.date.accessioned2013-05-28T08:19:38Z-
dc.date.available2013-05-28T08:19:38Z-
dc.date.issued2011-06-27-
dc.identifier.issn1932-6203-
dc.identifier.urihttp://hdl.handle.net/2445/43784-
dc.description.abstractRecent studies have shown aberrant expression of SOX11 in various types of aggressive B-cell neoplasms. To elucidate the molecular mechanisms leading to such deregulation, we performed a comprehensive SOX11 gene expression and epigenetic study in stem cells, normal hematopoietic cells and different lymphoid neoplasms. We observed that SOX11 expression is associated with unmethylated DNA and presence of activating histone marks (H3K9/14Ac and H3K4me3) in embryonic stem cells and some aggressive B-cell neoplasms. In contrast, adult stem cells, normal hematopoietic cells and other lymphoid neoplasms do not express SOX11. Such repression was associated with silencing histone marks H3K9me2 and H3K27me3. The SOX11 promoter of non-malignant cells was consistently unmethylated whereas lymphoid neoplasms with silenced SOX11 tended to acquire DNA hypermethylation. SOX11 silencing in cell lines was reversed by the histone deacetylase inhibitor SAHA but not by the DNA methyltransferase inhibitor AZA. These data indicate that, although DNA hypermethylation of SOX11 is frequent in lymphoid neoplasms, it seems to be functionally inert, as SOX11 is already silenced in the hematopoietic system. In contrast, the pathogenic role of SOX11 is associated with its de novo expression in some aggressive lymphoid malignancies, which is mediated by a shift from inactivating to activating histone modifications.-
dc.format.extent10 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherPublic Library of Science (PLoS)-
dc.relation.isformatofReproducció del document publicat a: http://dx.doi.org/10.1371/journal.pone.0021382-
dc.relation.ispartofPLoS One, 2011, vol. 6, num. 6, p. e21382-
dc.relation.urihttp://dx.doi.org/10.1371/journal.pone.0021382-
dc.rightscc-by (c) Vegliante, M.C. et al., 2011-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es-
dc.sourceArticles publicats en revistes (Fonaments Clínics)-
dc.subject.classificationLimfomes-
dc.subject.classificationHistones-
dc.subject.classificationCarcinogènesi-
dc.subject.otherLymphomas-
dc.subject.otherHistones-
dc.subject.otherCarcinogenesis-
dc.titleEpigenetic Activation of SOX11 in Lymphoid Neoplasms by Histone Modifications-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec606744-
dc.date.updated2013-05-28T08:19:38Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid21738649-
Appears in Collections:Articles publicats en revistes (Fonaments Clínics)

Files in This Item:
File Description SizeFormat 
606744.pdf763.18 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons